NCT03499743View on ClinicalTrials.gov

Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD.

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

April 20, 2018

Primary Completion Date

September 1, 2018

Study Completion Date

September 5, 2018

Conditions
IUD Insertion Pain
Interventions
DRUG

hyoscine butyl bromide

intake of 10 mg hyoscine butyl bromide (buscopan) orally in addition to a placebo similar to Celecoxib 2 hours before IUD insertion

DRUG

Celecoxib 200mg

Celecoxib 200mg (Celebrex® 200, Pfizer, USA) in addition to a placebo similar to hyoscine butyl bromide

DRUG

Placebo Oral Tablet

a placebo similar to hyoscine butyl bromide in addition to a placebo similar to Celecoxib.

Trial Locations (1)

11231

Obsterics and Gynecology Department, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03499743 - Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD. | Biotech Hunter | Biotech Hunter